Comparison of different intravenous regime of Dexmedetomidine On Characteristics of Spinal anaesthesia.

Comparison of Intravenous Bolus and Infusion of Dexmedetomidine On Characteristics of Subarachnoid Block - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/073114

Enrollment

Registered

2024-08-29

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: -

Interventions

Intervention1: Inj. dexmedetomidine Bolus in 100 ml NS given prior to SAB.: Inj dexmedetomidine Intravenous Bolus 0.5 microgram/kg over 15 min in studying effective in prolonging sensory and motor bl

Eligibility

Inclusion criteria

Inclusion criteria: ASA I II Patient having normal coagulation profile. Patient undergoing lower limb surgery and lower abdominal surgery.

Exclusion criteria

Exclusion criteria: ASA III IV V Emergency surgeries Unwilling patient Infection at site of injection Pre existing neurological disorders Any coagulation disorders Cardio and respi failure Allergy to local anaesthetic agents.

Design outcomes

Primary

Measure	Time frame
To study the effect of intravenous bolus and infusion of Dexmedetomidine on duration of sensory and motor block.Timepoint: 12 hours post operative	—

Secondary

Measure	Time frame
To evaluate haemodynamic instability and side effects following IV dexmedetomidine.Timepoint: 12 hours after end of surgery.	—

Countries

India

Contacts

Public ContactDr Anisha Chokshi

B.J.Medical College, Ahmedabad

abhinisha@gmail.com9824497076

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026